ABL Bio Inc. (KOSDAQ:298380)
South Korea flag South Korea · Delayed Price · Currency is KRW
65,500
-500 (-0.76%)
Jun 27, 2025, 3:30 PM KST

ABL Bio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,406,6661,443,6301,178,1561,099,1291,041,424
Market Cap Growth
28.81%22.53%7.19%5.54%-
Enterprise Value
3,344,3311,335,3371,126,3981,038,936-
Last Close Price
70200.0029900.0024600.0023000.0022100.00
PE Ratio
---342.55-
PS Ratio
123.2943.2217.9716.33195.31
PB Ratio
23.828.6315.9015.8118.61
P/TBV Ratio
24.818.9116.4716.4319.50
P/FCF Ratio
---15.69-
P/OCF Ratio
---15.24-
EV/Sales Ratio
121.0439.9817.1815.44-
EV/EBITDA Ratio
---321.37-
EV/EBIT Ratio
---1144.20-
EV/FCF Ratio
-35.37--14.83-
Debt / Equity Ratio
0.300.260.590.600.01
Debt / EBITDA Ratio
---12.94-
Debt / FCF Ratio
---0.60-
Asset Turnover
0.160.170.380.54-
Quick Ratio
1.672.241.711.095.01
Current Ratio
1.702.281.811.125.20
Return on Equity (ROE)
-69.34%-46.01%-3.69%5.12%-
Return on Assets (ROA)
-26.36%-18.93%-0.95%0.45%-
Return on Capital (ROIC)
-31.54%-22.56%-1.43%0.68%-
Return on Capital Employed (ROCE)
---0.80%-
Earnings Yield
-2.10%-3.85%-0.22%0.29%-4.18%
FCF Yield
-2.78%-5.43%-2.90%6.38%-4.02%
Buyback Yield / Dilution
-0.57%-0.37%-0.58%-1.27%-
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.